|
US6334997B1
(en)
|
1994-03-25 |
2002-01-01 |
Isotechnika, Inc. |
Method of using deuterated calcium channel blockers
|
|
CN1087725C
(zh)
|
1994-03-25 |
2002-07-17 |
同位素技术有限公司 |
用氘代方法增强药物效果
|
|
US5919785A
(en)
|
1996-04-03 |
1999-07-06 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
WO2003059265A2
(en)
|
2001-12-21 |
2003-07-24 |
Cytokinetics, Inc. |
Compositions and methods for treating heart failure
|
|
CA2511970C
(en)
|
2003-01-14 |
2012-06-26 |
Cytokinetics, Inc. |
Urea derivatives useful in the treatment of heart failure
|
|
WO2004064760A2
(en)
|
2003-01-21 |
2004-08-05 |
Archemix Corp. |
Aptamer therapeutics useful in ocular pharmacotherapy
|
|
ES2378620T3
(es)
|
2003-03-27 |
2012-04-16 |
Cytokinetics, Inc. |
Sulfonamidas para el tratamiento de insuficiencia cardiaca congestiva, sus composiciones y usos.
|
|
US7393852B2
(en)
|
2003-06-20 |
2008-07-01 |
Amgen Inc. |
Piperazine derivatives and methods of use
|
|
JP5080970B2
(ja)
|
2004-06-17 |
2012-11-21 |
サイトキネティクス・インコーポレーテッド |
心疾患を治療するための置換尿素誘導体
|
|
US20060173183A1
(en)
|
2004-12-31 |
2006-08-03 |
Alantos Pharmaceuticals, Inc., |
Multicyclic bis-amide MMP inhibitors
|
|
MX2007012883A
(es)
|
2005-04-22 |
2007-12-10 |
Wyeth Corp |
Derivados de dihidrobenzofurano y usos de los mismos.
|
|
EP1959962A2
(en)
|
2005-12-16 |
2008-08-27 |
Cytokinetics, Inc. |
Certain chemical entities, compositions, and methods
|
|
RU2318818C1
(ru)
|
2006-04-12 |
2008-03-10 |
Общество С Ограниченной Ответственностью "Исследовательский Институт Химического Разнообразия" |
Азагетероциклы, комбинаторная библиотека, фокусированная библиотека, фармацевтическая композиция и способ получения (варианты)
|
|
SA08290245B1
(ar)
|
2007-04-23 |
2012-02-12 |
استرازينيكا ايه بي |
مشتقات كربو كساميد جديدة من -n (8-اريل رباعي هيدرو نفثالين غير متجانس- 2- يل) أو -n (5-اريل كرومان غير متجانس -3-يل) لعلاج الألم
|
|
US20090192168A1
(en)
|
2008-01-04 |
2009-07-30 |
Alex Muci |
Compounds, Compositions and Methods
|
|
US20110275673A1
(en)
|
2008-09-19 |
2011-11-10 |
Yibin Xiang |
Inhibitors of sphingosine kinase 1
|
|
HRP20140371T1
(hr)
|
2009-05-15 |
2014-05-23 |
Novartis Ag |
Arilpiridini kao inhibitori sinteze aldosterona
|
|
US8592426B2
(en)
|
2011-01-24 |
2013-11-26 |
Hoffmann—La Roche Inc. |
Aryl-benzocycloalkyl amide derivatives
|
|
US8759380B2
(en)
*
|
2011-04-22 |
2014-06-24 |
Cytokinetics, Inc. |
Certain heterocycles, compositions thereof, and methods for their use
|
|
EP2760830B1
(en)
|
2011-09-27 |
2016-08-03 |
Bristol-Myers Squibb Company |
Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
|
|
EA024204B1
(ru)
|
2012-01-20 |
2016-08-31 |
Актелион Фармасьютиклз Лтд. |
Производные гетероциклических амидов в качестве антагонистов p2xрецептора
|
|
US9199945B2
(en)
|
2013-06-21 |
2015-12-01 |
MyoKardia, Inc. |
Cycloalkyl-substituted pyrimidinedione compounds
|
|
SMT202000071T1
(it)
|
2013-06-21 |
2020-03-13 |
Myokardia Inc |
Composti di pirimidinadione contro le condizioni cardiache
|
|
EP3080103B9
(en)
|
2013-12-11 |
2018-09-19 |
Biogen MA Inc. |
Biaryl compounds useful for the treatment of human diseases in oncology, neurology and immunology
|
|
US9663516B2
(en)
|
2014-12-18 |
2017-05-30 |
MyoKardia, Inc. |
Bicyclic-pyrimidinedione compounds
|
|
IL295547A
(en)
|
2015-01-22 |
2022-10-01 |
Myokardia Inc |
Piperidine-4-methylsulfonyl-modified urea compounds for the treatment of dilated cardiomyopathy (dcm)
|
|
MX2018003845A
(es)
*
|
2015-10-02 |
2018-06-18 |
Syngenta Participations Ag |
Derivados de oxadiazol microbicidas.
|
|
BR112018012390B1
(pt)
|
2015-12-17 |
2023-03-14 |
Syngenta Participations Ag |
Derivados de oxadiazol microbiocidas
|
|
EP3390398A1
(en)
|
2015-12-18 |
2018-10-24 |
Syngenta Participations AG |
Microbiocidal oxadiazole derivatives
|
|
EP3448519A4
(en)
|
2016-04-29 |
2020-01-22 |
Board Of Regents, The University Of Texas System |
SIGMA RECEPTOR BINDING
|
|
US11066396B2
(en)
*
|
2016-06-23 |
2021-07-20 |
Merck Sharp & Dohme Corp. |
3-aryl- heteroaryl substituted 5-trifluoromethyl oxadiazoles as histonedeacetylase 6 (HDAC6) inhibitors
|
|
EP3519416B1
(en)
|
2016-09-27 |
2021-03-31 |
Merck Sharp & Dohme Corp. |
Chromane, isochromane and dihydroisobenzofuran derivatives as mglur2-negative allosteric modulators, compositions, and their use
|
|
WO2018089433A1
(en)
|
2016-11-08 |
2018-05-17 |
Navitor Pharmaceuticals, Inc. |
PHENYL mTORC INHIBITORS AND USES THEREOF
|
|
JP2020023442A
(ja)
*
|
2016-12-19 |
2020-02-13 |
住友化学株式会社 |
オキサジアゾール化合物及び植物病害防除方法
|
|
WO2018156883A1
(en)
|
2017-02-23 |
2018-08-30 |
Board Of Regents, The University Of Texas System |
Methods of treatment for cancer, sterol homeostasis, and neurological diseases
|
|
JP7123956B2
(ja)
|
2017-02-28 |
2022-08-23 |
ヘリオイースト・ファーマシューティカル・カンパニー・リミテッド |
スピロ化合物およびその使用
|
|
FI3661514T3
(fi)
|
2017-08-04 |
2025-12-12 |
Myokardia Inc |
Mavakamteeni käytettäväksi hypertrofisen kardiomyopatian hoidossa
|
|
BR112020014428A2
(pt)
|
2018-01-19 |
2020-12-01 |
Cytokinetics, Inc. |
composto, composição farmacêutica, e, métodos para o tratamento de uma doença cardíaca em um indivíduo, para o tratamento de uma doença ou condição que está associada com cavidade ventricular esquerda pequena e obliteração da cavidade, contração hiperdinâmica do ventrículo esquerdo, isquemia do miocárdio ou fibrose cardíaca, para o tratamento de uma doença ou condição selecionada dentre distrofias musculares e doenças de armazenamento do glicogênio e para inibição do sarcômero cardíaco
|
|
BR112020018094A2
(pt)
|
2018-03-08 |
2020-12-22 |
Incyte Corporation |
Compostos de aminopirazina diol como inibidores de pi3k-¿
|
|
US10710994B2
(en)
|
2018-03-19 |
2020-07-14 |
Genentech, Inc. |
Oxadiazole transient receptor potential channel inhibitors
|
|
JP7610985B2
(ja)
|
2018-06-26 |
2025-01-09 |
サイトキネティックス， インコーポレイテッド |
心臓サルコメア阻害剤
|
|
EP3814342B1
(en)
*
|
2018-06-26 |
2022-07-27 |
Cytokinetics, Inc. |
Cardiac sarcomere inhibitors
|
|
JP7447089B2
(ja)
|
2018-08-31 |
2024-03-11 |
サイトキネティックス， インコーポレイテッド |
心筋サルコメア阻害剤
|
|
KR20210054510A
(ko)
|
2018-08-31 |
2021-05-13 |
제논 파마슈티칼스 인크. |
헤테로아릴-치환된 술폰아미드 화합물 및 치료제로서의 그의 용도
|
|
EP3999180B1
(en)
|
2019-07-17 |
2024-05-08 |
Cytokinetics, Inc. |
Polymorphs of (r)-n-(5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1h-inden-1-yl)-1-methyl-1h-pyrazole-4-carboxamide
|
|
HRP20240200T1
(hr)
|
2019-07-17 |
2024-04-26 |
Cytokinetics, Inc. |
Oralne formulacije inhibitora kardijskih sarkomera
|
|
CA3144974A1
(en)
|
2019-07-17 |
2021-01-21 |
Norma TOM |
Polymorphs of (r)-n-(5-(5-isopropyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1h-inden-1-yl)-2-methyl-2h-tetrazole-5-carboxamide
|
|
CA3190060A1
(en)
|
2020-08-28 |
2022-03-03 |
MyoKardia, Inc. |
Methods of treatment with myosin modulator
|
|
MX2023010125A
(es)
|
2021-03-04 |
2023-09-11 |
Cytokinetics Inc |
Inhibidores del sarcomero cardiaco.
|
|
EP4370116B1
(en)
|
2021-07-16 |
2025-01-15 |
Cytokinetics, Inc. |
Aficamten dosage regimens for treating obstructive hypertrophic cardiomyopathy
|
|
US12077069B2
(en)
|
2021-08-06 |
2024-09-03 |
Dorel Juvenile Group, Inc. |
Child restraint
|
|
US20230338378A1
(en)
|
2022-04-26 |
2023-10-26 |
MyoKardia, Inc. |
Methods of Administering Myosin Inhibitors
|